Ameriprise’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
273,445
+193,978
| +244% | +$10.4M | ﹤0.01% | 1539 |
|
|
2025
Q1 | $3.22M | Buy |
79,467
+64,295
| +424% | +$2.6M | ﹤0.01% | 2618 |
|
|
2024
Q4 | $422K | Buy |
+15,172
| New | +$422K | ﹤0.01% | 3564 |
|
|
2024
Q2 | – | Sell |
-8,578
| Closed | -$217K | – | 3858 |
|
|
2024
Q1 | $217K | Sell |
8,578
-238,315
| -97% | -$6.02M | ﹤0.01% | 3667 |
|
|
2023
Q4 | $5.76M | Buy |
246,893
+226,255
| +1,096% | +$5.28M | ﹤0.01% | 2242 |
|
|
2023
Q3 | $1.04M | Buy |
20,638
+15,191
| +279% | +$768K | ﹤0.01% | 3125 |
|
|
2023
Q2 | $254K | Sell |
5,447
-185
| -3% | -$8.64K | ﹤0.01% | 3653 |
|
|
2023
Q1 | $215K | Sell |
5,632
-8,873
| -61% | -$339K | ﹤0.01% | 3707 |
|
|
2022
Q4 | $794K | Sell |
14,505
-84,228
| -85% | -$4.61M | ﹤0.01% | 3230 |
|
|
2022
Q3 | $3.36M | Buy |
+98,733
| New | +$3.36M | ﹤0.01% | 2507 |
|